The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Biernacka, J M, Sangkuhl, K, Jenkins, G, Whaley, R M, Barman, P, Batzler, A, Altman, R B, Arolt, V +24 more·2015·Translational Psychiatry
DOI 10.1038/tp.2015.47

Cited by (139)

Items 101–139 of 139

  1. Big Data Guided Interventions: Predicting Treatment Response
    Alexander Kautzky, Rupert R. Lanzenberger, Siegfried F. Kasper · 2019 · Springer eBooks
  2. WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling
    Ankita Bachhawat Jaykumar, Derk D. Binns, Clinton A. Taylor, Anthony N. Anselmo, Sachith Gallolu Kankanamalage, Shari G. Birnbaum, Kimberly M. Huber, Melanie H. Cobb · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Correction: Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
    Danyang Li, Oliver Pain, Chiara Fabbri, Win Lee Edwin Wong, Chris Wai Hang Lo, Stephan Ripke, Annamaria Cattaneo, Daniel Souery, Mojca Zvezdana Dernovšek, Neven Henigsberg et al. · 2024 · Translational Psychiatry
  4. Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l’aide des scores de risque polygéniques : Rapport sur l’étude CAN-BIND-1
    Leen Magarbeh, Samar S. M. Elsheikh, Farhana Islam, Victoria S. Marshe, Xiaoyu Men, Emytis Tavakoli, Martin Kronenbuerger, Stefan M. Kloiber, Benicio Noronha Frey, Roumen V. Milev et al. · 2025 · The Canadian Journal of Psychiatry
  5. From Pharmacogenetics to Imaging Pharmacogenetics: Elucidating Mechanisms of Antidepressant Response
    Eva J. Brandl, Henrik Walter · 2017 · Pharmacogenomics
  6. Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram
    Yun‐Ai Su, Chad Bousman, Qi Liu, Xiaozhen Lv, Jitao Li, Jingyu Lin, Xin Yu, Li Tian, Tianmei Si · 2021 · Pharmacogenetics and Genomics
  7. Current methods for predicting therapeutic response in patients with depressive disorders
    Галкин Станислав Алексеевич, Svetlana А. Ivanova, Nikolay A. Bokhan · 2022 · S S Korsakov Journal of Neurology and Psychiatry
  8. Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral blood.
    Teresa Torres, Daniel Boloc, Natàlia Rodríguez, Ana Blázquez, María Teresa Plana, Eva Varela, Patricia Gassó, Albert Martínez-Pinteño, Luisa Lázaro, Joan Albert Arnáiz et al. · 2020 · PubMed Central
  9. Differential effects of N-linked glycosylation of Vstm5 at multiple sites on surface expression and filopodia formation
    A-Ram Lee, Sulgi Kim, Kwang Woo Ko, Chul‐Seung Park · 2017 · PLoS ONE
  10. Applying Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders
    Y. W. Francis Lam · 2021 · Elsevier eBooks
  11. Three Decades of SSRI/SNRI Withdrawal Research: A Bibliometric and Science-Mapping Study
    Erdoğdu Akça · 2025 · The European Research Journal
  12. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs
    Chiara Fabbri, Alessandro Serretti · 2016 · Springer eBooks
  13. Highlights on Pharmacogenetics and Pharmacogenomics in Depression
    Chiara Fabbri, Alessandro Serretti · 2017 · Springer eBooks
  14. Genomic Basis of Psychiatric Illnesses and Response to Psychiatric Drug Treatment Modalities
    Evangelia Eirini Tsermpini, Μαρία Σκώκου, Zoe Kordou, George P. Patrinos · 2019 · Elsevier eBooks
  15. Editorial for “Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder”
    Abhinav Srinath, Sharbel G. Romanos, Sean B. Lyne, Benjamin Leporq, Janne Koskimäki, Romuald Girard · 2020 · Journal of Magnetic Resonance Imaging
  16. WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling
    Ankita Bachhawat Jaykumar, Derk D. Binns, Clinton A. Taylor, Anthony N. Anselmo, Sachith Gallolu Kankanamalage, Shari G. Birnbaum, Kimberly M. Huber, Melanie H. Cobb · 2024 · eLife
  17. WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling
    Ankita Bachhawat Jaykumar, Derk D. Binns, Clinton A. Taylor, Anthony N. Anselmo, Shari G. Birnbaum, Kimberly M. Huber, Melanie H. Cobb · 2024 · eLife
  18. WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling
    Ankita Bachhawat Jaykumar, Derk D. Binns, Clinton A. Taylor, Anthony N. Anselmo, Sachith Gallolu Kankanamalage, Shari G. Birnbaum, Kimberly M. Huber, Melanie H. Cobb · 2025 · eLife
  19. Article Open Access
    Holly Lawford‐Smith · 2015
  20. Statistical dissection of pharmacogenetics with machine learning
    Moira Verbelen · 2017 · Research Portal (King's College London)
  21. Pharmacogenomics of antidepressant drugs: perspectives for the personalization of treatment in depression
    Fabbri · 2018
  22. The role of pharmacogenetics in the treatment of depression
    Airiss R. Chan, Ilona Gorbovskaya, Daniel J. Müller · 2019
  23. Genomics of major depressive disorder
    Douglas F. Levinson · 2019 · Elsevier eBooks
  24. Pharmacogenomics of treatment response in major depressive disorder
    Joanna M. Biernacka, Ahmed T. Ahmed, Balwinder Singh, Mark A. Frye · 2019 · Elsevier eBooks
  25. The effects of circadian food entrainment on the dopamine system and behavioral measures of affect in the male rat.
    Hanna Opiol · 2019 · Spectrum Research Repository (Concordia University)
  26. Sampling Statistical Errors in Big Data Research: 3 Cases of Breast Cancer Research
    Han-Jun Cho, Eui Seok Jeong · 2021 · medRxiv
  27. Faculty Opinions recommendation of Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts.
    John I. Nürnberger · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  28. Investigation on the atomization characteristics and structure parameters of alcohol-based fuel in small stove
    Quanxian Hua, Haigang Shi, Quan Gao, Yixuan Li, Jing Bai, Peng Zheng, Pan Li · 2022 · International Journal of Chemical Reactor Engineering
  29. Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders
    Hirotaka Yamagata, Ryouichi Tsunedomi, Toshiharu Kamishikiryo, Ayumi Kobayashi, Tomoe Seki, Masaaki Kobayashi, Kosuke Hagiwara, Norihiro Yamada, Chong Chen, Shusaku Uchida et al. · 2023 · Heliyon
  30. Literaturverzeichnis
    2025 · Elsevier eBooks
  31. Integrating multi-polygenic scores for enhanced prediction of antidepressant treatment outcomes in an East Asian population
    Shu-Chin Lin, Chiu-Ping Fang, Chia-Lin Hsu, An-Nie Chung, Tzu-Ting Chen, Kai-Hsiang Hsu, Chueh-Chun Yeh, Jingyi Zheng, Chao-Yu Liu, Chi-Shin Wu et al. · 2025 · Neuropsychopharmacology
  32. An Exploration of the Genetic Architecture of Pregnancy-Related Linea Nigra and Its Relationship With Pigmentation Phenotypes
    Svetlana Bivol, Mathias Seviiri, Lucía Colodro‐Conde, Brittany L. Mitchell, Catherine M. Olsen, David C. Whiteman, Matthew H. Law, Penelope A. Lind, Jodie N. Painter, Sarah Elizabeth Medland · 2025 · Twin Research and Human Genetics
  33. Esketamine ameliorates depression-like behavior in mice via modulation of the NRG1–ErbB4 pathway
    Hang Yu, Yuqiong Zhu, Jie Wang, Yifan He, Hui Li, Shuxuan Li, Ning Wang, Nuo Chen, Juan Chen, Hongtao Song et al. · 2026 · Frontiers in Psychiatry
  34. Novel strategies for pharmacogenetic and metabolomic analysis of antidepressant treatment response in depression
    Kenneth Chappell · 2023 · theses.fr (ABES)
  35. The Global Compatibility Index (GCI): A Variance-Weighted Pharmacogenomic Scoring System Demonstrates Near-Perfect Cross-Mode Consistency (ICC = 0.994) and Improves Warfarin Dose Prediction Over the CPIC Algorithm in 5,475 Patients Across Four Continents, with Multi-Drug Validation Across 10 Independent Datasets
    D. Venkatesan · 2026 · Research Square
  36. Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depression
    Ke Hu, Chris Wai Hang Lo, Swapnil Awasthi, Oliver Pain, Madhurbain Singh, Yeeun Ahn, Katherine Jean Aitchison, Bernhard Theodor Baune, Joanna M. Biernacka, Guido Bondolfi et al. · 2026 · medRxiv
  37. NRG1-ErbB4 signaling in the mPFC mediates adolescent social isolation-induced depressive-like behaviors
    J LIU, Xin-Yu Yang, Dingyu Wu, Hao Chen, Shu-Ji Li, Xiaowen Li, Jian‐Ming Yang, Tianming Gao · 2026 · Pharmacological Research
  38. WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signaling
    Ankita Bachhawat Jaykumar, Derk D. Binns, Clinton A. Taylor, Anthony N. Anselmo, Sachith Gallolu Kankanamalage, Shari G. Birnbaum, Kimberly M. Huber, Melanie H. Cobb · 2026 · eLife
  39. Association of neurotransmitter-based polygenic scores with antidepressant treatment outcomes in patients with major depressive disorder
    Nigussie Tadesse Sharew, Scott Richard Clark, Volker Arolt, Jürgen Brockmöller, Chia-Hui Chen, Katharina Domschke, Daniel K. Hall‐Flavin, Ari Illi, Olli Kampman, Esa V. J. Leinonen et al. · 2026 · medRxiv